MIR502

Across TCGA pan-cancer cohorts, MIR502 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR502 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR502 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR502 expression acts as an unfavorable survival marker.

HNSC, OV, and LUSC are the cancer types where MIR502 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.177	0.674	.001	132	view →
OV	OS	Tertile	II,III,IV	0.369	0.846	<.001	108	view →
LUSC	OS	Tertile	All	0.304	0.780	<.001	90	view →
LIHC	DFS	Tertile	All	0.044	0.553	<.001	36	view →
UCEC	OS	Tertile	III,IV	0.091	0.593	.025	24	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR502–HNSC (OS)

Open the HNSC breakdown →